Analysis of key genes and pathways in breast ductal carcinoma in situ
Breast most cancers (BC) stays the commonest most cancers in females. Due to this fact, the current research aimed to establish key genes concerned within the carcinogenesis of BC and to discover their prognostic values by integrating bioinformatics instruments. The gene expression profiles of 46 ductal carcinoma in situ (DCIS) and three regular breast tissues from the GSE59248 dataset have been downloaded. Differentially expressed genes (DEGs) have been subsequently recognized utilizing the net device GEO2R and a useful enrichment evaluation was carried out. As well as, a protein-protein interplay (PPI) community was constructed and the highest eight hub genes have been recognized.
The prognostic values of the hub genes have been additional investigated. A complete of 316 DEGs, together with 32 upregulated and 284 downregulated genes, have been recognized. Moreover, eight hub genes, together with lipase E hormone delicate kind, patatin like phospholipase area containing 2, adiponectin C1Q and collagen area containing (ADIPOQ), peroxisome proliferator activated receptor γ (PPARG), fatty acid binding protein 4 (FABP4), diacylglycerol O-acyltransferase 2, lipoprotein lipase (LPL) and leptin (LEP), have been recognized from the PPI community.
The downregulated expression of ADIPOQ, PPARG, FABP4, LPL and LEP was considerably related to poor total survival in sufferers with DCIS. Due to this fact, these genes could function potential biomarkers for prognosis prediction. Nevertheless, additional investigation is required to validate the outcomes obtained within the current research.
Trametinib |
|||
HY-10999 | MedChemExpress | 100mg | EUR 465.38 |
Description: Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
Trametinib |
|||
MBS3606330-100mg | MyBiosource | 100mg | EUR 245 |
Trametinib |
|||
MBS3606330-10mg | MyBiosource | 10mg | EUR 200 |
Trametinib |
|||
MBS3606330-200mg | MyBiosource | 200mg | EUR 275 |
Trametinib |
|||
MBS3606330-50mg | MyBiosource | 50mg | EUR 215 |
Trametinib |
|||
MBS3606330-5x200mg | MyBiosource | 5x200mg | EUR 920 |
Trametinib |
|||
T2125-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Trametinib |
Trametinib |
|||
T2125-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Trametinib |
Trametinib |
|||
T2125-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Trametinib |
Trametinib |
|||
T2125-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Trametinib |
Trametinib |
|||
T2125-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Trametinib |
Trametinib-13C6 |
|||
C988931 | Toronto Research Chemicals | 0.5mg | EUR 4669 |
Trametinib-13C6 |
|||
HY-10999S1 | MedChemExpress | 1mg | Ask for price |
Description: Trametinib-13C6 is the 13C-labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
Ripa lysate (strong) |
|||
E1WP106 | EnoGene | 50ML | EUR 60 |
Trametinib-13C,d3 |
|||
HY-10999S2 | MedChemExpress | 1mg | EUR 1007.59 |
Description: Trametinib-13C,d3 is the 13C- and deuterium labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
Trametinib-d4 |
|||
HY-10999S | MedChemExpress | 1mg | Ask for price |
Description: Trametinib-d4 is the deuterium labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
Trametinib-d4 |
|||
T712602 | Toronto Research Chemicals | 100mg | EUR 4500 |
Deiodo Trametinib |
|||
D397050 | Toronto Research Chemicals | 100mg | EUR 800 |
Description: 871700-65-1 |
Trametinib (GSK1120212) |
|||
A3018-200 | ApexBio | 200 mg | EUR 153.6 |
Description: MAPK Signaling|MEK1/2 |
Trametinib (GSK1120212) |
|||
A3018-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: MAPK Signaling|MEK1/2 |
Trametinib (GSK1120212) |
|||
A3018-50 | ApexBio | 50 mg | EUR 76.8 |
Description: MAPK Signaling|MEK1/2 |
Trametinib (GSK1120212) |
|||
A3018-500 | ApexBio | 500 mg | EUR 324 |
Description: MAPK Signaling|MEK1/2 |
Trametinib (GSK1120212) |
|||
A3018-S | ApexBio | Evaluation Sample | EUR 24 |
Description: MAPK Signaling|MEK1/2 |
Trametinib (GSK1120212) |
|||
MBS576333-100mg | MyBiosource | 100mg | EUR 180 |
Trametinib (GSK1120212) |
|||
MBS576333-10mg | MyBiosource | 10mg | EUR 145 |
Trametinib (GSK1120212) |
|||
MBS576333-200mg | MyBiosource | 200mg | EUR 210 |
Trametinib (GSK1120212) |
|||
MBS576333-50mg | MyBiosource | 50mg | EUR 155 |
Trametinib (GSK1120212) |
|||
MBS576333-5mg | MyBiosource | 5mg | EUR 130 |
Trametinib DMSO solvate |
|||
123211 | MedKoo Biosciences | 10.0mg | EUR 90 |
Trametinib DMSO solvate |
|||
A3887-10 | ApexBio | 10 mg | EUR 40 |
Description: MAPK Signaling|MEK1/2 |
Trametinib DMSO solvate |
|||
A3887-100 | ApexBio | 100 mg | EUR 95.2 |
Description: MAPK Signaling|MEK1/2 |
Trametinib DMSO solvate |
|||
A3887-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: MAPK Signaling|MEK1/2 |
Trametinib DMSO solvate |
|||
A3887-50 | ApexBio | 50 mg | EUR 64 |
Description: MAPK Signaling|MEK1/2 |
Trametinib (DMSO solvate) |
|||
HY-10999A | MedChemExpress | 100mg | EUR 75.76 |
Description: Trametinib (DMSO solvate) (GSK-1120212 (DMSO solvate);JTP-74057 (DMSO solvate)) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib (DMSO solvate) activates autophagy and induces apoptosis[1][2]. |
Trametinib DMSO solvate |
|||
MBS5752199-100mg | MyBiosource | 100mg | EUR 180 |
Trametinib DMSO solvate |
|||
MBS5752199-10mg | MyBiosource | 10mg | EUR 145 |
Trametinib DMSO solvate |
|||
MBS5752199-200mg | MyBiosource | 200mg | EUR 225 |
Trametinib DMSO solvate |
|||
MBS5752199-25mg | MyBiosource | 25mg | EUR 145 |
Trametinib DMSO solvate |
|||
MBS5752199-50mg | MyBiosource | 50mg | EUR 160 |
Trametinib (DMSO solvate) |
|||
MBS3845880-100mg | MyBiosource | 100mg | EUR 425 |
Trametinib (DMSO solvate) |
|||
MBS3845880-10mg | MyBiosource | 10mg | EUR 140 |
Trametinib (DMSO solvate) |
|||
MBS3845880-25mg | MyBiosource | 25mg | EUR 200 |
Trametinib (DMSO solvate) |
|||
MBS3845880-50mg | MyBiosource | 50mg | EUR 275 |
Trametinib (DMSO solvate) |
|||
MBS3845880-5x100mg | MyBiosource | 5x100mg | EUR 1910 |
Trametinib DMSO solvate |
|||
MBS3600640-100mg | MyBiosource | 100mg | EUR 245 |
Trametinib DMSO solvate |
|||
MBS3600640-10mg | MyBiosource | 10mg | EUR 200 |
Trametinib DMSO solvate |
|||
MBS3600640-200mg | MyBiosource | 200mg | EUR 290 |
Trametinib DMSO solvate |
|||
MBS3600640-25mg | MyBiosource | 25mg | EUR 200 |
Trametinib DMSO solvate |
|||
MBS3600640-50mg | MyBiosource | 50mg | EUR 220 |
Trametinib Impurity-I |
|||
T138340 | Toronto Research Chemicals | 10mg | EUR 800 |
Description: 1383430-03-2 |
Trametinib (DMSO Solvate) |
|||
T314310 | Toronto Research Chemicals | 100mg | EUR 800 |
Description: 1187431-43-1 |
Trametinib (DMSO solvate) |
|||
T5857-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Trametinib (DMSO solvate) |
Trametinib (DMSO solvate) |
|||
T5857-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Trametinib (DMSO solvate) |
Trametinib (DMSO solvate) |
|||
T5857-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Trametinib (DMSO solvate) |
Trametinib (DMSO solvate) |
|||
T5857-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Trametinib (DMSO solvate) |
Trametinib (DMSO solvate) |
|||
T5857-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Trametinib (DMSO solvate) |
RIPA Lysis Buffer (Strong) |
|||
abx090624-100l | Abbexa | 100 µl | EUR 150 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-100ml | Abbexa | 100 ml | EUR 260.4 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-1ml | Abbexa | 1 ml | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
abx090624-200l | Abbexa | 200 µl | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-100mL | Elabscience Biotech | 100mL | EUR 80 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-20mL | Elabscience Biotech | 20mL | EUR 25 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-50mL | Elabscience Biotech | 50mL | EUR 60 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-each | Elabscience Biotech | each | Ask for price |
Strong RIPA Lysis Buffer |
|||
EZPS03-1 | Shanghai WSHT Biotechnology | 100mL | EUR 15 |
RIPA Lysis Buffer (Strong) |
|||
HY-K1001 | MedChemExpress | 100 mL | EUR 176.4 |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-100mL | MyBiosource | 100mL | EUR 210 |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-5x100mL | MyBiosource | 5x100mL | EUR 640 |
Carbol Fuchsin (ZN,Strong) |
|||
S005-125ML | EWC Diagnostics | 1 unit | EUR 3.16 |
Description: Carbol Fuchsin (ZN,Strong) |
Carbol Fuchsin (ZN,Strong) |
|||
S005-500ML | EWC Diagnostics | 1 unit | EUR 10.92 |
Description: Carbol Fuchsin (ZN,Strong) |
WB Stripping Solution Strong |
|||
05677-65 | NACALAI TESQUE | 500ML | EUR 142.8 |
OOMC00081-10MG - Trametinib |
|||
OOMC00081-10MG | Aviva Systems Biology | 10mg | EUR 59 |
OOMC00081-50MG - Trametinib |
|||
OOMC00081-50MG | Aviva Systems Biology | 50mg | EUR 199 |
Trametinib [CAS# 871700-17-3] |
|||
T-8123 | LC LABORATORIES | 10 mg | EUR 38 |
Trametinib dimethyl sulfoxide |
|||
414033 | MedKoo Biosciences | 25.0mg | EUR 228 |
Clear Seal Strong Sheet (100) |
|||
MAAB-0685 | Westburg | each | EUR 255.61 |
HiDecal (Strong decalcifying solution) |
|||
R085-500ML | EWC Diagnostics | 1 unit | EUR 21.95 |
Description: HiDecal (Strong decalcifying solution) |
Arg-SEC Mobile Phase(Strong) |
|||
17000-51 | NACALAI TESQUE | 1L | EUR 105 |
Pierce Seal Strong Roll - 1ROLL |
|||
PCR0636 | Scientific Laboratory Supplies | 1ROLL | EUR 1314.9 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-100mg | MyBiosource | 100mg | EUR 210 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-10mg | MyBiosource | 10mg | EUR 145 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-1mLinDMSO | MyBiosource | 1mL(inDMSO) | EUR 145 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-50mg | MyBiosource | 50mg | EUR 170 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-5mg | MyBiosource | 5mg | EUR 130 |
Pierce Seal Strong Sheets - PK100 |
|||
PCR0632 | Scientific Laboratory Supplies | PK100 | EUR 140.4 |
Tissue/cell lysis buffer(Strong) |
|||
RM17482 | Abclonal | 10mL | EUR 53.14 |
replacement tip Kit strong thick |
|||
INS2090 | Scientific Laboratory Supplies | EACH | EUR 8.33 |
Modified Duncan Strong (DS) Medium |
|||
M1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) Medium |
Pierce Seal Strong Roll610mX78mm - 1ROLL |
|||
PCR0628 | Scientific Laboratory Supplies | 1ROLL | EUR 1104.3 |
Trametinib, DMSO Solvate [CAS# 1187431-43-1] |
|||
T-8188 | LC LABORATORIES | 10 mg | EUR 38 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-100mL | Shanghai WSHT Biotechnology | 100mL | EUR 9.6 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-500mL | Shanghai WSHT Biotechnology | 500mL | EUR 28.8 |
Tweezers Fine Strong CF Tips - EACH |
|||
INS5058 | Scientific Laboratory Supplies | EACH | EUR 37.6 |
Tweezers Flat Strong CF Tips - EACH |
|||
INS5100 | Scientific Laboratory Supplies | EACH | EUR 43.92 |
PCR Foil Seal Strong Sheets - PK100 |
|||
PCR0528 | Scientific Laboratory Supplies | PK100 | EUR 211.95 |
EP Reagent Sodium Hypochlorite Sol. Strong - 500ML |
|||
10816005 | Scientific Laboratory Supplies | 500ML | EUR 136.35 |
Pierce Seal Strong Sample Roll - 1ROLL |
|||
PCR0630 | Scientific Laboratory Supplies | 1ROLL | EUR 59.63 |
replacement tip Kit strong thick - EACH |
|||
INS2058 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
replacement tip Kit strong point - EACH |
|||
INS2094 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
Modified Duncan Strong (DS) HiVeg Medium |
|||
MV1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) HiVeg Medium |
anti PAI-1 (very strong for human) |
|||
MBS480230-1mg | MyBiosource | 1mg | EUR 790 |
anti PAI-1 (very strong for human) |
|||
MBS480230-5x1mg | MyBiosource | 5x1mg | EUR 3315 |
Strong RIPA Lysis Buffer (without inhibitors) |
|||
EZPS03-2 | Shanghai WSHT Biotechnology | 100mL | EUR 12.6 |
EP Reagent Sodium Hydroxide Sol. Strong - 1L |
|||
1081404 | Scientific Laboratory Supplies | 1L | EUR 191.7 |
Tweezers, Rubis Sturdy, Strong Pointed, 115mm, 4.5€ |
|||
25046-1 | Polysciences Europe GmbH | 1EA | EUR 52.92 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-25 | Polysciences Europe GmbH | 25g | EUR 479.52 |
Description: 9015-51-4 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-5 | Polysciences Europe GmbH | 5g | EUR 125.28 |
Description: 9015-51-4 |
Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
|||
M-R-1013161 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
|||
M-R-1015229 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
Seralite SRA-400, Strong Basic Anion Exchange Resin |
|||
52228 | Sisco Laboratories | 500 Gms | EUR 5.82 |
Description: Part A |
Seralite SRC-120, Strong Acid Cation Exchange Resin |
|||
14891 | Sisco Laboratories | 500 Gms | EUR 3.76 |
Description: Part A |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-1 | Polysciences Europe GmbH | 1000ml | EUR 213.84 |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-250 | Polysciences Europe GmbH | 250ml | EUR 69.12 |
A510, Type 2 Macroporous Strong Base Rsin, Chloride Form |
|||
50223-1 | Polysciences Europe GmbH | 1000ml | EUR 160.92 |
Description: 69011-15-0 |
DiagAg™ Strong Anion Exchange Agarose Particles, 40 μm |
|||
DAG-CL23-08 | Creative Diagnostics | 25 mL | EUR 920 |
A510, Type 2 Macroporous Strong Base Resin, Chloride Form |
|||
50223-250 | Polysciences Europe GmbH | 250ml | EUR 52.92 |
Description: 69011-15-0 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-1 | Polysciences Europe GmbH | 1000ml | EUR 160.92 |
Description: 9052-45-3 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-250 | Polysciences Europe GmbH | 250ml | EUR 52.92 |
Description: 9052-45-3 |
Optically clear sealing film for qPCR, Strong Bond, for PP plates, 100/pk |
|||
MS1000-PCR2 | Benchmark Scientific | 1 each | EUR 149.35 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 24-45 µm |
|||
DAG-YS23-27 | Creative Diagnostics | 25 mL | EUR 680 |
A prognosis-predictive nomogram of ovarian cancer with two immune-related genes: CDC20B and PNPLA5
Ovarian carcinoma (OV) is likely one of the most deadly gynecological malignancies globally, and the general 5-year survival charge of OV was 47% in 2018 based on American information. To extend the survival charge of sufferers with OV, many researchers have sought to establish biomarkers that act as each prognosis-predictive markers and remedy targets.
Nevertheless, most of those haven’t been appropriate for scientific software. The current research geared toward establishing a predictive prognostic nomogram of OV utilizing the genes recognized by combining The Most cancers Genome Atlas (TCGA) dataset for OV with the immune rating calculated by the Estimation of STromal and Immune cells in MAlignant Tumor tissues utilizing Expression information algorithm. Firstly, the algorithm was used to calculate the immune rating of sufferers with OV within the TCGA-OV dataset.
Secondly, differentially expressed genes (DEGs) between high and low immune rating tissues have been recognized, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes evaluation was carried out to foretell the features of those DEGs. Thirdly, univariate, multivariate and Lasso Cox’s regression analyses have been carried out step-by-step, and 6 prognosis-relatedDEGs have been recognized.
Then, Kaplan-Myer survival curves have been generated for these genes and validated by evaluating their expression ranges to additional slender the vary of DEGs and to calculate the danger rating. Two genes have been recognized, cell division cycle 20B and patatin-like phospholipase area containing 5, which have been each proven to have increased expression ranges in OV tissues and to be considerably related to the prognosis of OV.
Subsequent, a nomogram was created utilizing these two genes and age, and utilizing the receiver working attribute (ROC) curve and calibration curve, the effectiveness of the nomogram was validated. Lastly, an exterior validation was carried out for this nomogram. The ROC confirmed that the areas beneath the curve (AUCs) of the 3- and 5-year total survival predictions for the nomogram have been 0.678 and 0.62, respectively. Furthermore, the ROC of the exterior validation mannequin confirmed that the AUCs of the 3- and 5-year have been 0.699 and 0.643, respectively, demonstrating the effectiveness of the generated nomogram. In conclusion, the current research has recognized two immune-related genes as biomarkers that reliably predict total survival in OV. These biomarkers may also be potential molecular targets of immune remedy to deal with sufferers with OV.
RIPA Lysis Buffer (Strong) |
|||
HY-K1001 | MedChemExpress | 100 mL | EUR 176.4 |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-100mL | MyBiosource | 100mL | EUR 210 |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-5x100mL | MyBiosource | 5x100mL | EUR 640 |
Carbol Fuchsin (ZN,Strong) |
|||
S005-125ML | EWC Diagnostics | 1 unit | EUR 3.16 |
Description: Carbol Fuchsin (ZN,Strong) |
Carbol Fuchsin (ZN,Strong) |
|||
S005-500ML | EWC Diagnostics | 1 unit | EUR 10.92 |
Description: Carbol Fuchsin (ZN,Strong) |
WB Stripping Solution Strong |
|||
05677-65 | NACALAI TESQUE | 500ML | EUR 142.8 |
Clear Seal Strong Sheet (100) |
|||
MAAB-0685 | Westburg | each | EUR 255.61 |
HiDecal (Strong decalcifying solution) |
|||
R085-500ML | EWC Diagnostics | 1 unit | EUR 21.95 |
Description: HiDecal (Strong decalcifying solution) |
Arg-SEC Mobile Phase(Strong) |
|||
17000-51 | NACALAI TESQUE | 1L | EUR 105 |
Pierce Seal Strong Roll - 1ROLL |
|||
PCR0636 | Scientific Laboratory Supplies | 1ROLL | EUR 1314.9 |
Pierce Seal Strong Sheets - PK100 |
|||
PCR0632 | Scientific Laboratory Supplies | PK100 | EUR 140.4 |
Tissue/cell lysis buffer(Strong) |
|||
RM17482 | Abclonal | 10mL | EUR 53.14 |
replacement tip Kit strong thick |
|||
INS2090 | Scientific Laboratory Supplies | EACH | EUR 8.33 |
Modified Duncan Strong (DS) Medium |
|||
M1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) Medium |
Pierce Seal Strong Roll610mX78mm - 1ROLL |
|||
PCR0628 | Scientific Laboratory Supplies | 1ROLL | EUR 1104.3 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-100mL | Shanghai WSHT Biotechnology | 100mL | EUR 9.6 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-500mL | Shanghai WSHT Biotechnology | 500mL | EUR 28.8 |
Tweezers Fine Strong CF Tips - EACH |
|||
INS5058 | Scientific Laboratory Supplies | EACH | EUR 37.6 |
Tweezers Flat Strong CF Tips - EACH |
|||
INS5100 | Scientific Laboratory Supplies | EACH | EUR 43.92 |
PCR Foil Seal Strong Sheets - PK100 |
|||
PCR0528 | Scientific Laboratory Supplies | PK100 | EUR 211.95 |
EP Reagent Sodium Hypochlorite Sol. Strong - 500ML |
|||
10816005 | Scientific Laboratory Supplies | 500ML | EUR 136.35 |
Pierce Seal Strong Sample Roll - 1ROLL |
|||
PCR0630 | Scientific Laboratory Supplies | 1ROLL | EUR 59.63 |
replacement tip Kit strong thick - EACH |
|||
INS2058 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
replacement tip Kit strong point - EACH |
|||
INS2094 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
Modified Duncan Strong (DS) HiVeg Medium |
|||
MV1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) HiVeg Medium |
anti PAI-1 (very strong for human) |
|||
MBS480230-1mg | MyBiosource | 1mg | EUR 790 |
anti PAI-1 (very strong for human) |
|||
MBS480230-5x1mg | MyBiosource | 5x1mg | EUR 3315 |
Strong RIPA Lysis Buffer (without inhibitors) |
|||
EZPS03-2 | Shanghai WSHT Biotechnology | 100mL | EUR 12.6 |
EP Reagent Sodium Hydroxide Sol. Strong - 1L |
|||
1081404 | Scientific Laboratory Supplies | 1L | EUR 191.7 |
Tweezers, Rubis Sturdy, Strong Pointed, 115mm, 4.5€ |
|||
25046-1 | Polysciences Europe GmbH | 1EA | EUR 52.92 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-25 | Polysciences Europe GmbH | 25g | EUR 479.52 |
Description: 9015-51-4 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-5 | Polysciences Europe GmbH | 5g | EUR 125.28 |
Description: 9015-51-4 |
Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
|||
M-R-1013161 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
|||
M-R-1015229 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
Seralite SRA-400, Strong Basic Anion Exchange Resin |
|||
52228 | Sisco Laboratories | 500 Gms | EUR 5.82 |
Description: Part A |
Seralite SRC-120, Strong Acid Cation Exchange Resin |
|||
14891 | Sisco Laboratories | 500 Gms | EUR 3.76 |
Description: Part A |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-1 | Polysciences Europe GmbH | 1000ml | EUR 213.84 |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-250 | Polysciences Europe GmbH | 250ml | EUR 69.12 |
A510, Type 2 Macroporous Strong Base Rsin, Chloride Form |
|||
50223-1 | Polysciences Europe GmbH | 1000ml | EUR 160.92 |
Description: 69011-15-0 |
DiagAg™ Strong Anion Exchange Agarose Particles, 40 μm |
|||
DAG-CL23-08 | Creative Diagnostics | 25 mL | EUR 920 |
A510, Type 2 Macroporous Strong Base Resin, Chloride Form |
|||
50223-250 | Polysciences Europe GmbH | 250ml | EUR 52.92 |
Description: 69011-15-0 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-1 | Polysciences Europe GmbH | 1000ml | EUR 160.92 |
Description: 9052-45-3 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-250 | Polysciences Europe GmbH | 250ml | EUR 52.92 |
Description: 9052-45-3 |
Optically clear sealing film for qPCR, Strong Bond, for PP plates, 100/pk |
|||
MS1000-PCR2 | Benchmark Scientific | 1 each | EUR 149.35 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 24-45 µm |
|||
DAG-YS23-27 | Creative Diagnostics | 25 mL | EUR 680 |
Rapamycin |
|||
41810000-1 | Bio-WORLD | 10 mg | EUR 67.17 |
Rapamycin |
|||
41810000-2 | Bio-WORLD | 100 mg | EUR 207.39 |
Rapamycin |
|||
41810000-3 | Bio-WORLD | 50 mg | EUR 115.48 |
Rapamycin |
|||
41810000-4 | Bio-WORLD | 500 mg | EUR 468.99 |
Rapamycin |
|||
30037-94 | NACALAI TESQUE | 100UG | EUR 138.6 |
Rapamycin |
|||
27062 | BPS Bioscience | 50 mg | EUR 135 |
Description: Immunosuppressant, related to FK-506, but without calcineurin inhibitory activity even when complexed to FK-506 binding protein. Selectively blocks signaling that leads to p70 S6 kinase activation (IC50 = 50 pM). |
Rapamycin |
|||
22470-54 | NACALAI TESQUE | 100ug | EUR 175.95 |
Description: 53123-88-9 |
Rapamycin |
|||
1568-5 | Biovision | each | EUR 339.6 |
Rapamycin |
|||
1568-50 | Biovision | each | EUR 1396.8 |
Rapamycin |
|||
abx076788-100l | Abbexa | 100 µl | EUR 118.75 |
Rapamycin |
|||
abx076788-1ml | Abbexa | 1 ml | Ask for price |
Rapamycin |
|||
abx076788-200l | Abbexa | 200 µl | EUR 300 |
Rapamycin |
|||
20-abx076788 | Abbexa |
|
|
Rapamycin |
|||
20-abx185560 | Abbexa |
|
|
Rapamycin |
|||
G613 | ABM | 100 mg | EUR 800 |
Rapamycin |
|||
GA7417 | Glentham Life Sciences | 5mg | EUR 181.03 |
Rapamycin |
|||
GA7417-100 | Glentham Life Sciences | 100 | EUR 197.7 |
Rapamycin |
|||
GA7417-100MG | Glentham Life Sciences | 100 mg | EUR 274.8 |
Rapamycin |
|||
GA7417-25 | Glentham Life Sciences | 25 | EUR 63.3 |
Rapamycin |
|||
GA7417-25MG | Glentham Life Sciences | 25 mg | EUR 112.8 |
Rapamycin |
|||
GA7417-5 | Glentham Life Sciences | 5 | EUR 23.8 |
Rapamycin |
|||
GA7417-50 | Glentham Life Sciences | 50 | EUR 118.7 |
Rapamycin |
|||
GA7417-50MG | Glentham Life Sciences | 50 mg | EUR 180 |
Rapamycin |
|||
GA7417-5MG | Glentham Life Sciences | 5 mg | EUR 64.8 |
Rapamycin |
|||
MBS132175-100mg | MyBiosource | 100mg | EUR 1065 |
Rapamycin |
|||
MBS132175-500mg | MyBiosource | 500mg | EUR 2775 |
Rapamycin |
|||
HY-10219 | MedChemExpress | 200mg | EUR 272.73 |
Description: Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[1]. Rapamycin is an autophagy activator, an immunosuppressant[2]. |
Rapamycin |
|||
E1B1842 | EnoGene | 1mg | EUR 60 |
Rapamycin |
|||
MBS515013-100mg | MyBiosource | 100mg | EUR 665 |
Rapamycin |
|||
MBS515013-20mg | MyBiosource | 20mg | EUR 320 |
Rapamycin |
|||
MBS515013-5x100mg | MyBiosource | 5x100mg | EUR 2740 |
Rapamycin |
|||
MBS3604884-100mg | MyBiosource | 100mg | EUR 210 |
Rapamycin |
|||
MBS3604884-200mg | MyBiosource | 200mg | EUR 240 |
Rapamycin |
|||
MBS3604884-50mg | MyBiosource | 50mg | EUR 195 |
Rapamycin |
|||
MBS3604884-5x200mg | MyBiosource | 5x200mg | EUR 760 |
Rapamycin |
|||
MBS407517-100mg | MyBiosource | 100mg | EUR 175 |
Rapamycin |
|||
MBS407517-1g | MyBiosource | 1g | EUR 450 |
Rapamycin |
|||
MBS407517-5x100mg | MyBiosource | 5x100mg | EUR 730 |
Rapamycin |
|||
MBS407517-5x1g | MyBiosource | 5x1g | EUR 1970 |
Rapamycin |
|||
MBS696245-10mg | MyBiosource | 10mg | EUR 235 |
Rapamycin |
|||
MBS696245-1mg | MyBiosource | 1mg | EUR 135 |
Rapamycin |
|||
MBS696245-5x10mg | MyBiosource | 5x10mg | EUR 1005 |
Rapamycin |
|||
MBS807957-25mg | MyBiosource | 25mg | EUR 450 |
Rapamycin |
|||
MBS807957-5mg | MyBiosource | 5mg | EUR 260 |
Rapamycin |
|||
MBS807957-5x25mg | MyBiosource | 5x25mg | EUR 1770 |
Rapamycin |
|||
MBS807957-5x5mg | MyBiosource | 5x5mg | EUR 905 |
Rapamycin |
|||
MBS8579821-1mg | MyBiosource | 1mg | EUR 155 |
Rapamycin |
|||
MBS8579821-5x1mg | MyBiosource | 5x1mg | EUR 555 |
Rapamycin |
|||
R001-10MG | TOKU-E | 10 mg | EUR 152.4 |
Description: 53123-88-9 |
Rapamycin |
|||
R001-25MG | TOKU-E | 25 mg | EUR 191.52 |
Description: 53123-88-9 |
Rapamycin |
|||
T1537-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
T1537-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
T1537-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
T1537-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
T1537-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
SIH-212-25MG | Stressmarq | 25 mg | EUR 276 |
Rapamycin |
|||
SIH-212-5MG | Stressmarq | 5 mg | EUR 110.4 |
Rapamycin |
|||
tlrl-rap-5 | InvivoGen FR | 5 x 5 mg | EUR 248.85 |
Rapamycin, 100mg |
|||
R5312 | ACTGene | 100mg | EUR 607.18 |
Rapamycin, 100mg |
|||
R5312-100mg | ACTGene | each | EUR 902.4 |
Rapamycin, >99% |
|||
BC082-050 | GenDepot | 50mg | EUR 142 |
Rapamycin, >99% |
|||
BC082-100 | GenDepot | 100mg | EUR 176 |
Rapamycin, >99% |
|||
BC082-250 | GenDepot | 250mg | EUR 250 |
Rapamycin, >99% |
|||
BC082-500 | GenDepot | 500mg | EUR 385 |
Rapamycin (>85%) |
|||
R124000 | Toronto Research Chemicals | 100mg | EUR 80 |
Description: 53123-88-9 |
Rapamycin (GMP) |
|||
HY-10219G | MedChemExpress | Get quote | Ask for price |
Description: Rapamycin (Sirolimus) (GMP) is Rapamycin (HY-10219) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Rapamycin is a potent and specific mTOR inhibitor[1][2][3]. |
Rapamycin-13C, D3 |
|||
ESS0567-5mg | ESSchemco | 5 mg | EUR 840 |
Description: Sirolimus-13C, D3 |
Rapamycin-13C,d3 |
|||
HY-10219S1 | MedChemExpress | Get quote | Ask for price |
Description: Rapamycin-13C,d3 (Sirolimus-13C,d3; AY-22989-13C,d3) is the 13C and deuterium labeled Rapamycin (HY-10219)[1]. Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[2]. Rapamycin is an autophagy activator, an immunosuppressant[3]. |
Rapamycin-D3 |
|||
ESS0404-5mg | ESSchemco | 5 mg | EUR 630 |
Description: Sirolimus-D3 |
Seco Rapamycin |
|||
HY-19555 | MedChemExpress | 50mg | EUR 2704.8 |
Description: Seco Rapamycin (Secorapamycin A) is the ring-opened product of Rapamycin. Seco-rapamycin is reported not to affect the mTOR function[1]. |
Rapamycin-d3 |
|||
HY-10219S | MedChemExpress | 1 mg | EUR 119.05 |
Description: Rapamycin-d3 is the deuterium labeled Rapamycin. Rapamycin is a potent and specific mTOR inhibitor with an IC50of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[1]. Rapamycin is an autophagy activator, an immunosuppressant[2]. |
Seco Rapamycin |
|||
MBS5799522-5mg | MyBiosource | 5(mg | EUR 915 |
Seco Rapamycin |
|||
MBS5799522-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Rapamycin, 10mg |
|||
R5312-10mg | ACTGene | each | EUR 244.8 |
Rapamycin-d3 |
|||
T12691-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Rapamycin-d3 |
Rapamycin-d3 |
|||
T12691-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Rapamycin-d3 |
Rapamycin-d3 |
|||
T12691-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Rapamycin-d3 |
Rapamycin-d3 |
|||
T12691-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Rapamycin-d3 |
Rapamycin-d3 |
|||
T12691-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Rapamycin-d3 |
Seco Rapamycin |
|||
T38963-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Seco Rapamycin |
Seco Rapamycin |
|||
T38963-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Seco Rapamycin |
Seco Rapamycin |
|||
T38963-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Seco Rapamycin |
Seco Rapamycin |
|||
T38963-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Seco Rapamycin |
Seco Rapamycin |
|||
T38963-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Seco Rapamycin |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, Low Capacity |
|||
DAG-YS23-28 | Creative Diagnostics | 25 mL | EUR 680 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, High Capacity |
|||
DAG-YS23-29 | Creative Diagnostics | 25 mL | EUR 680 |
Rapamycin (Sirolimus) |
|||
A8167-100 | ApexBio | 100 mg | EUR 154.4 |
Description: PI3K/Akt/mTOR Signaling|mTOR |
Rapamycin (Sirolimus) |
|||
A8167-25 | ApexBio | 25 mg | EUR 81.6 |
Description: PI3K/Akt/mTOR Signaling|mTOR |
Rapamycin (Sirolimus) |
|||
A8167-5 | ApexBio | 5 mg | EUR 40 |
Description: PI3K/Akt/mTOR Signaling|mTOR |
Rapamycin (Sirolimus) |
|||
A8167-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 48 |
Description: PI3K/Akt/mTOR Signaling|mTOR |
Rapamycin (Sirolimus) |
|||
A8167-S | ApexBio | Evaluation Sample | EUR 24 |
Description: PI3K/Akt/mTOR Signaling|mTOR |
Sirolimus (Rapamycin) |
|||
100766 | MedKoo Biosciences | 25.0mg | EUR 90 |
Rapamycin (Sirolimus) |
|||
E1KS1039 | EnoGene | 50mg | EUR 120 |
Rapamycin (Sirolimus) |
|||
MBS575148-100mg | MyBiosource | 100mg | EUR 155 |
Rapamycin (Sirolimus) |
|||
MBS575148-200mg | MyBiosource | 200mg | EUR 185 |
Rapamycin (Sirolimus) |
|||
MBS575148-25mg | MyBiosource | 25mg | EUR 135 |
Rapamycin (Sirolimus) |
|||
MBS575148-500mg | MyBiosource | 500mg | EUR 260 |
Rapamycin (Sirolimus) |
|||
MBS575148-50mg | MyBiosource | 50mg | EUR 145 |
Rapamycin (Sirolimus) |
|||
MBS386035-100mg | MyBiosource | 100mg | EUR 160 |
Rapamycin (Sirolimus) |
|||
MBS386035-1mLinDMSO | MyBiosource | 1mL(inDMSO) | EUR 140 |
Rapamycin (Sirolimus) |
|||
MBS386035-50mg | MyBiosource | 50mg | EUR 145 |
Rapamycin (Sirolimus) |
|||
MBS386035-5mg | MyBiosource | 5mg | EUR 130 |
Rapamycin (Sirolimus) |
|||
MBS386035-5x100mg | MyBiosource | 5x100mg | EUR 715 |
Rapamycin (Sirolimus) |
|||
MBS8506576-50mg | MyBiosource | 50mg | EUR 210 |
Rapamycin (Sirolimus) |
|||
MBS8506576-5x50mg | MyBiosource | 5x50mg | EUR 800 |
EZSolution? Rapamycin |
|||
1746-5 | Biovision | each | EUR 326.4 |
Foil seals, strong bonding for cold storage (-200 to 110°C) and DMSO, for PP plates, 100/pk |
|||
MS1000-F2 | Benchmark Scientific | 1 each | EUR 149.35 |
Rapamycin analog-2 |
|||
HY-153511 | MedChemExpress | Get quote | Ask for price |
Description: Rapamycin analog-2 (compound A) is a Rapamycin analog[1]. |
Estrogen receptor (ER) IHC control with strong, moderate, low/negative expressersHumanBreastBreastIHC control |
|||
ERC083 | Pantomics | 1.5mm | EUR 50 |
rapamycin derivative 1 |
|||
R454500 | Toronto Research Chemicals | 25mg | EUR 1800 |
rapamycin derivative 2 |
|||
R574880 | Toronto Research Chemicals | 100mg | EUR 9200 |
TOR | Target of rapamycin |
|||
AS12-2608 | Agrisera AB | 50 µg | EUR 302 |
OOMC00007-10MG - Rapamycin |
|||
OOMC00007-10MG | Aviva Systems Biology | 10mg | EUR 69 |
OOMC00007-50MG - Rapamycin |
|||
OOMC00007-50MG | Aviva Systems Biology | 50mg | EUR 249 |
Rapamycin-31,42-Diester Impurity |
|||
R124015 | Toronto Research Chemicals | 50mg | EUR 1938 |
Rapamycin [CAS# 53123-88-9] |
|||
R-5000 | LC LABORATORIES | 50 mg | EUR 48 |
42-O-Formyl Rapamycin |
|||
ESS0554-5mg | ESSchemco | 5 mg | EUR 525 |
Description: Everolimus EP Impurity E |
33-O-Formyl Rapamycin |
|||
F699010 | Toronto Research Chemicals | 10mg | EUR 1728 |
Seco Rapamycin (sodium salt) |
|||
HY-19555A | MedChemExpress | 1mg | EUR 2077.95 |
Description: Seco Rapamycin sodium salt is the ring-opened product of Rapamycin. Seco-rapamycin is reported not to affect the mTOR function. |
Seco Rapamycin ethyl ester |
|||
HY-133770 | MedChemExpress | 10 mg | EUR 2380.99 |
Description: Seco Rapamycin ethyl ester is an open-ring metabolite of Rapamycin derivative. Seco-rapamycin is reported not to affect the mTOR function[1]. |
7-O-Demethyl rapamycin |
|||
HY-123691 | MedChemExpress | Get quote | Ask for price |
Description: 7-O-Demethyl rapamycin, a derivative of Rapamycin (HY-10219), has antifungal activity and immunosuppressant properties. 7-O-Demethyl rapamycin has useful tumor cell growth-inhibiting activity[1]. |
7-O-Demethyl rapamycin |
|||
MBS5775613-10mg | MyBiosource | 10mg | EUR 2020 |
7-O-Demethyl rapamycin |
|||
MBS5775613-25mg | MyBiosource | 25mg | EUR 1995 |
7-O-Demethyl rapamycin |
|||
MBS5775613-5mg | MyBiosource | 5(mg | EUR 1235 |
Seco Rapamycin sodium salt |
|||
MBS5756112-25mg | MyBiosource | 25mg | EUR 1405 |
Seco Rapamycin sodium salt |
|||
MBS5756112-50mg | MyBiosource | 50mg | EUR 2410 |
Seco Rapamycin sodium salt |
|||
MBS5756112-5x50mg | MyBiosource | 5x50mg | EUR 10695 |
Seco Rapamycin sodium salt |
|||
MBS3602049-10mg | MyBiosource | 10mg | EUR 655 |
Seco Rapamycin sodium salt |
|||
MBS3602049-25mg | MyBiosource | 25mg | EUR 1075 |
Seco Rapamycin sodium salt |
|||
MBS3602049-50mg | MyBiosource | 50mg | EUR 1630 |
Seco Rapamycin sodium salt |
|||
MBS3602049-5mg | MyBiosource | 5mg | EUR 465 |
Seco Rapamycin sodium salt |
|||
MBS3602049-5x50mg | MyBiosource | 5x50mg | EUR 7015 |
7-O-Demethyl Rapamycin |
|||
MBS6080732-25mg | MyBiosource | 2.5(mg | EUR 665 |
7-O-Demethyl Rapamycin |
|||
MBS6080732-5x25mg | MyBiosource | 5x2.5mg | EUR 2845 |
7-O-Demethyl rapamycin |
|||
T25882-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
|||
T25882-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
|||
T25882-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
|||
T25882-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
|||
T25882-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 7-O-Demethyl rapamycin |
Seco Rapamycin sodium salt |
|||
T19558-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
|||
T19558-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
|||
T19558-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
|||
T19558-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
|||
T19558-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Seco Rapamycin sodium salt |
42-(2-Tetrazolyl)rapamycin |
|||
HY-12424A | MedChemExpress | 1mg | EUR 311.69 |
Description: 42-(2-Tetrazolyl)rapamycin is a proagent compound of a rapamycin analog extracted from patent US 20080171763 A1, Example 1. Rapamycin is a specific mTOR inhibitor. |